LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
Public ClinicalTrials.gov record NCT05171491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Evaluation of LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Correlate performance of LungLB Test with outcome of a scheduled biopsy.
Study identification
- NCT ID
- NCT05171491
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 425 participants
Conditions and interventions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 26, 2022 (Actual)
- Primary completion
- Dec 30, 2023 (Actual)
- Completion
- Sep 2, 2024 (Estimated)
- Last update posted
- Jun 13, 2024
2022 – 2024
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site 04 | Los Angeles | California | 90095 | — |
| Clinical Site 05 | Bay Pines | Florida | 33744 | — |
| Clinical Site 03 | Miami | Florida | 33136 | — |
| Clinical Site 07 | Hines | Illinois | 60141 | — |
| Clinical Site 27 | Kansas City | Kansas | 64111 | — |
| Clinical Site 12 | Wichita | Kansas | 67218 | — |
| Clinical Site 08 | Kansas City | Missouri | 64128 | — |
| Clinical Site 18 | Reno | Nevada | 89502 | — |
| Clinical Site 01 | New York | New York | 10029 | — |
| Clinical Site 25 | Columbia | South Carolina | 29203 | — |
| Clinical Site 02 | Houston | Texas | 77030 | — |
| Clinical Site 32 | Milwaukee | Wisconsin | 53295 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05171491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 13, 2024 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05171491 live on ClinicalTrials.gov.